Renaissance Technologies LLC Sells 123,900 Shares of Strata Critical Medical $SRTA

Renaissance Technologies LLC lowered its position in Strata Critical Medical (NASDAQ:SRTA) by 20.7% during the first quarter, Holdings Channel reports. The firm owned 474,886 shares of the company’s stock after selling 123,900 shares during the period. Renaissance Technologies LLC’s holdings in Strata Critical Medical were worth $1,985,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Seelaus Asset Management LLC increased its position in shares of Strata Critical Medical by 32.7% during the first quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company’s stock worth $102,000 after buying an additional 6,000 shares during the period. Granite Investment Partners LLC raised its stake in Strata Critical Medical by 77.0% during the first quarter. Granite Investment Partners LLC now owns 18,181 shares of the company’s stock worth $76,000 after buying an additional 7,911 shares during the last quarter. Principal Financial Group Inc. acquired a new position in Strata Critical Medical in the first quarter valued at $537,000. Finally, Dimensional Fund Advisors LP lifted its holdings in Strata Critical Medical by 11.9% in the first quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company’s stock valued at $6,759,000 after buying an additional 172,154 shares during the period. 47.36% of the stock is owned by institutional investors.

Analyst Ratings Changes

Separately, Weiss Ratings cut shares of Strata Critical Medical from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $8.00.

Strata Critical Medical Stock Performance

Shares of SRTA opened at $6.03 on Wednesday. The firm has a market capitalization of $521.78 million, a price-to-earnings ratio of -75.38 and a beta of 2.25. Strata Critical Medical has a 52-week low of $3.85 and a 52-week high of $6.50. The firm has a 50 day simple moving average of $5.45.

Insider Activity

In related news, CEO William A. Heyburn sold 31,671 shares of the business’s stock in a transaction on Monday, June 8th. The shares were sold at an average price of $5.87, for a total transaction of $185,908.77. Following the transaction, the chief executive officer owned 1,548,997 shares in the company, valued at $9,092,612.39. The trade was a 2.00% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Amir Cohen sold 4,655 shares of the business’s stock in a transaction on Monday, June 8th. The shares were sold at an average price of $5.87, for a total transaction of $27,324.85. Following the transaction, the chief accounting officer owned 146,608 shares in the company, valued at $860,588.96. The trade was a 3.08% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 116,931 shares of company stock worth $687,184 in the last quarter. 15.50% of the stock is owned by corporate insiders.

Strata Critical Medical Profile

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.